摘要
门静脉高压症是由于门静脉血流受阻、血液瘀滞,导致门静脉压力增高的一组病理综合征。我国门静脉高压症90%的病因是肝硬变,肝硬化门静脉高压症合并食道、胃底静脉曲张破裂出血是门静脉高压症中最凶险的并发症,出血量大,死亡率高,手术危险性大。肝硬化门静脉高压症的微创治疗已成为当代研究的重点,主要是通过降低门静脉压力及肝门腔压力梯度达到治疗目的。
Portal hypertension due to portal vein obstruction,blood stasis,leading to increased portal pressure in a group of pathological syndrome.Of 90% of portal hypertension is the cause of cirrhosis;cirrhotic portal hypertension combined esophageal and gastric varices bleeding in portal hypertension is the most dangerous complications,bleeding volume,high mortality,major surgical risk.Cirrhotic portal hypertension has become aminimally invasive treatment of the focus of contemporary research,mainly by reducing portal pressure and hepatic portosystemic pressure gradient for therapeutic purposes.
出处
《中外医学研究》
2011年第22期147-149,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
门静脉高压症
上消化道出血
微创治疗
Portal hypertension
Upper gastrointestinal bleeding
Minimally invasive treatment
